Evaluating the surgical and oncological outcomes of hepatic artery variations in minimally invasive pancreaticoduodenectomy: insights from 2023 data at a high-volume pancreatic center
HAV and CR-HAV do not significantly impact overall or progression-free survival in patients undergoing MIPD. While HAV is associated with longer operation times, other perioperative and oncological outcomes remain comparable between HAV/CR-HAV (+) and (-) groups.
Authors
- Junchao Guo (ORCID: https://orcid.org/0000-0002-7878-8315)
- Jiashu Han (ORCID: https://orcid.org/0009-0007-4000-9893)
- Menghua Dai (ORCID: https://orcid.org/0000-0002-7273-6282)
- Qiang Xu (ORCID: https://orcid.org/0000-0002-6785-7178)
- Tianyu Li (ORCID: https://orcid.org/0000-0002-3719-1459)
- Dongming Zhang (ORCID: https://orcid.org/0000-0003-2016-8639)
- Lin Chen (ORCID: https://orcid.org/0000-0002-6453-7996)
- Xianlin Han (ORCID: https://orcid.org/0000-0002-8615-2413)
- Weibin Wang (ORCID: https://orcid.org/0000-0002-6659-9680)
- Liangbo Dong
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Baotou Central Hospital (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1186/s12957-025-03704-6
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- Peking Union Medical College Hospital
- Peking Union Medical College